Site-specific gene conversion promoter and gene therapeutic

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060258602A1
SERIAL NO

10527597

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

It is intended to provide a preparation whereby an oligonucleotide is efficiently transferred into a cell and the localization thereof in nucleus is promoted, a preparation for facilitating the conversion of the base sequence of a target genomic gene, and a preparation for gene therapy. Namely, a preparation for facilitating site-specific gene conversion which comprises at least a collagen and an oligonucleotide for gene conversion; a preparation for site-specific gene therapy which comprises at least a collagen and an oligonucleotide for gene conversion; a method of arbitrarily converting a specific base on a genomic gene in the nucleus of a cell which comprises bringing the above-described preparation for facilitating gene conversion into contact with the cell; and an preparation for facilitating oligonucleotide intranuclear localization which comprises at least a collagen and an oligonucleoitde.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DAINIPPON SUMITOMO PHARMA CO LTDOSAKA JAPAN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ando, Yukio Kumamoto-shi, JP 36 285
Nagahara, Shunji Ibaraki-shi, JP 8 12
Nakamura, Masaaki Kumamoto-shi, JP 76 884

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation